Concepedia

Ken‐ichi Morishita

KM

2

Publications

71

Citations

2

H-Index

2007

Active since

Affiliations

Okayama University(Current)

Okayama University of Science

Ken‐ichi Morishita is an author at Okayama University specializing in drug discovery, drug resistance, and pharmacotherapy.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryDrug ResistancePharmacotherapyNatural SciencesMedicinal ChemistryMolecular Pharmacology

Publications per year

2007–2008

2

Publications

2

The First Potent Subtype‐Selective Retinoid X Receptor (RXR) Agonist Possessing a 3‐Isopropoxy‐4‐isopropylphenylamino Moiety, NEt‐3IP (RXRα/β‐dual agonist)

Kayo Takamatsu, Atsushi Takano, Nobumasa Yakushiji et al. · ChemMedChem · 2008 · 49 citations

Reduction of Lipophilicity at the Lipophilic Domain of RXR Agonists Enables Production of Subtype Preference: RXRα‐Preferential Agonist Possessing a Sulfonamide Moiety

Kayo Takamatsu, Atsushi Takano, Nobumasa Yakushiji et al. · ChemMedChem · 2007 · 22 citations

Pharmacotherapy, Drug Resistance, Molecular Pharmacology +16

Rows per page

1–2 of 2